Letter abstract


Nature Cell Biology 11, 951 - 957 (2009)
Published online: 20 July 2009 | doi:10.1038/ncb1906

A regulatory pathway involving Notch1/bold beta-catenin/Isl1 determines cardiac progenitor cell fate.

Chulan Kwon2, Li Qian1,2, Paul Cheng1,2, Vishal Nigam2,2, Joshua Arnold2 & Deepak Srivastava2

Top

Regulation of multipotent cardiac progenitor cell (CPC) expansion and subsequent differentiation into cardiomyocytes, smooth muscle or endothelial cells is a fundamental aspect of basic cardiovascular biology and cardiac regenerative medicine. However, the mechanisms governing these decisions remain unclear. Here, we show that Wnt/beta-catenin signalling, which promotes expansion of CPCs1, 2, 3, is negatively regulated by Notch1-mediated control of phosphorylated beta-catenin accumulation within CPCs, and that Notch1 activity in CPCs is required for their differentiation. Notch1 positively, and beta-catenin negatively, regulated expression of the cardiac transcription factors, Isl1, Myocd and Smyd1. Surprisingly, disruption of Isl1, normally expressed transiently in CPCs before their differentiation4, resulted in expansion of CPCs in vivo and in an embryonic stem (ES) cell system. Furthermore, Isl1 was required for CPC differentiation into cardiomyocyte and smooth muscle cells, but not endothelial cells. These findings reveal a regulatory network controlling CPC expansion and cell fate that involves unanticipated functions of beta-catenin, Notch1 and Isl1 that may be leveraged for regenerative approaches involving CPCs.

Top
  1. These authors contributed equally in this work.
  2. Gladstone Institute of Cardiovascular Disease and Departments of Pediatrics and Biochemistry & Biophysics, University of California, San Francisco, 1650 Owens Street, San Francisco, CA 94158, USA.

Correspondence to: Chulan Kwon2 e-mail: ckwon@gladstone.ucsf.edu

Correspondence to: Deepak Srivastava2 e-mail: dsrivastava@gladstone.ucsf.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Pluripotency and tumorigenicity

Nature Genetics News and Views (01 Dec 2002)


Extra navigation

Subscribe to Nature Cell Biology

Subscribe

Open Innovation Challenges

naturejobs